Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 17-20

  Koro, Carol E ^a,b,c   Bowlin, Steven J ^a   Bourgeois, Nancy ^a   Fedder, Donald O ^b  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; DIET THERAPY; EARLY DIAGNOSIS; FEMALE; HEALTH CARE COST; HUMAN; INSULIN TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD GLUCOSE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; ETHNIC GROUPS; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 1042280201     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.17     Document Type: Article

References (16)

1. Gilmer TP, O'Conner PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care 20:1847-1853, 1997
2. Hogan P, Dall T, Nikolov P, American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
3. UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
4. Holman RR, Tumer RC: Optimising blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements. Diabet Med 5:582-588, 1988
5. Johnson JL, Wolf SL, Kabadi UM: Efficacy of insulin and sulfonylurea combination therapy in type 2 diabetes: a meta-analysis of the randomized placebo-controlled trials. Arch Intern Med 156:259-264, 1996
6. Nicolucci A, Cavaliere D, Scorpiglione N, Carinci F, Capani F, Tognoni G, Benedetti MM: A comprehensive assessment of the avoidability of long-term complications of diabetes: a case-control study. Diabetes Care 19:927-933, 1996
7. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 23 (Suppl. 1):S32-S42, 2000
8. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 21 (Suppl. 1):S23-S31, 1998
9. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
10. Centers for Disease Control and Prevention: NHANES 1999-2000 public data release file documentation [article online], 2000. Available from http://www.cdc.gov/nchs/about/major/nhanes/currentnhanes.htm. Accessed 7 August 2003
11. Centers for Disease Control and Prevention, National Center for Health Statistics: Vital and Health Statistics, Plan and Operation of the Third National Health and Nutrition and Examination Survey, 1988-1994. Rockville, MD, U.S. Department of Health and Human Services, Public Health Service, 1994, p. 4-485 (DHHS publ. no. PHS 94-1308, series 1, no. 32)
12. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
13. Primus Corporation: Glycated Hemoglobin and Plasma Protein Analyzer Operator's Manual for the Diabetes Care Test Package of the CLC330 and CLC385. Kansas City, MO, Primus Corporation, 1999
14. Shah BV, Barnwell BG, Bieler GS: SUDAAN User's Manual, Release 6.40. Research Triangle Park, NC, Research Triangle Institute, 1995
15. El-Kibbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Philips LS: Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med 163:69-75, 2003
16. Turner RC, Cull CA, Frighi V, Holman RR, for the U.K. Prospective Diabetes Study (UKPDS) Group: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 281:2005-2012, 1999